Table 2

- Comparing numbers of readmissions with demographics, comorbidities, and functional status.

VariablesSingle readmission (n=163)Multiple readmissions (n=37)P-values
Gender
Male81 (49.7)16 (43.2)0.300
Female82 (50.3)21 (56.7)
Diabetes mellitus
Yes113 (69.3)29 (78.4)0.186
No50 (30.7)8 (21.6)
Hypertension
Yes131 (80.4)29 (78.4)0.470
No32 (19.6)8 (21.6)
Heart failure with reduced ejection fraction
Yes25 (15.3)11 (29.7)0.040
No138 (84.7)26 (70.3)
Heart failure with preserved ejection fraction
Yes36 (22.1)3 (8.1)0.037
No127 (77.9)34 (91.9)
Stroke
Yes42 (25.8)7 (18.9)0.258
No121 (74.2)30 (81.1)
Atrial fibrillation
Yes20 (12.3)4 (10.8)0.532
No143 (87.7)33 (89.2)
Chronic kidney disease is not on Renal replacement therapy
Yes40 (24.5)7 (18.9)0.311
No123 (75.5)30 (81.1)
End stage renal disease on Renal replacement therapy
Yes15 (9.2)1 (2.7)0.164
No148 (90.8)36 (97.3)
Interstitial lung disease
Yes5 (3.1)1 (2.7)0.693
No158 (96.9)36 (97.3)
Bronchial asthma
Yes24 (14.7)5 (13.5)0.543
No139 (85.3)32 (86.5)
Chronic obstructive pulmonary disease
Yes13 (8.0)6 (16.2)0.112
No150 (92.0)31 (83.8)
Thyroid disease
Yes12 (7.4)5 (13.5)0.184
No151 92.6)32 (86.5)
Dementia
Yes24 (14.7)6 (16.2)0.495
No139 (85.3)31 (83.8)
Connective tissue disease
Yes5 (3.1)1 (2.7)0.693
No158 (96.9)36 (97.3)
Ischemic heart disease
Yes17 10.4)5 (13.5)0.384
No146 (89.6)32 (86.5)
Renal transplant
Yes8 (4.9)1 (2.7)0.479
No155 (95.1)36 (97.3)
Bronchiectasis
Yes4 (2.4)1 (2.7)0.645
No159 97.5)36 (97.3)
Venous thromboembolism
Yes5 (3.1)2 (5.4)0.382
No158 (96.9)35 (94.6)
Malignancy
Yes11 (6.7)3 (8.1)0.498
No152 (93.2)34 (91.9)
Depression
Yes2 (1.2)1 (2.7)0.505
No161 (98.8)36 (97.3)

Values are presented as numbers and percentages (%).